FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
FOR PRENATAL DIAGNOSIS

A new FDA-cleared test using fluorescence in situ hybridization allows the rapid detection of the most common abnormalities of chromosome number. These include trisomies of chromosomes 13, 18 and 21 (Down syndrome) and numerical abnormalities of the X and Y chromosomes (Turner and Klinefelter syndromes, XXX and XYY). These disorders account for about 65% or all abnormalities identified at the time of amniocentesis. The test does not detect complete or partial trisomies of the other autosomes, nor partial trisomies of these specific chromosomes. Structural abnormalities of these chromosomes and the other autosomes also are not detected. 

REASONS FOR REFERRAL

RESULTS

SPECIMEN REQUIREMENTS